Skip to main content
. 2008 Jul;3(4):1115–1124. doi: 10.2215/CJN.05351107

Table 1.

Frequencies of pretransplant cardiac evaluations according to recipient IHD risk group

Cohort (n = 27,786) [no. (%)] High Risk (n = 16,029) [no. (%)] Lower Risk (n = 11,757) [no. (%)]
Cardiac evaluation historya
    any cardiac evaluation 12,876 (46.3) 10,482 (65.4) 2394 (20.4)
        nonacute 11,335 (40.8) 9138 (57.0) 2197 (18.7)
        acute 1541 (5.6) 1344 (8.4) 197 (1.7)
    noninvasive stress test 11,341 (40.8) 9120 (56.9) 2221 (18.9)
        nonacute 10,318 (37.1) 8251 (51.5) 2067 (17.6)
        acute 1023 (3.7) 869 (5.4) 154 (1.3)
    coronary angiography 5385 (19.4) 4957 (30.9) 428 (3.6)
        nonacute 4286 (15.4) 3932 (24.5) 354 (3.0)
        acute 1099 (4.0) 1025 (6.4) 74 (0.6)
    stress test and angiographyb 3850 (13.9) 3595 (22.4) 255 (2.2)
Evaluation within 1-yr before transplanta
    any cardiac evaluation 8619 (31.0) 7337 (45.8) 1282 (10.9)
        nonacute 7576 (27.3) 6378 (39.8) 1198 (10.2)
        acute 1043 (3.8) 959 (6.0) 84 (0.7)
    noninvasive stress test 7222 (26.0) 6034 (37.6) 1188 (10.1)
        nonacute 6589 (27.3) 5466 (34.1) 1123 (9.6)
        acute 633 (2.3) 568 (3.5) 65 (0.6)
    coronary angiography 3031 (10.9) 2882 (18.0) 149 (1.3)
        nonacute 2357 (8.5) 2230 (13.9) 127 (1.1)
        acute 674 (2.4) 652 (4.1) 22 (0.2)
    stress test and angiographyb 1634 (5.9) 1579 (9.8) 55 (0.5)
a

CE performed during hospital admissions (except admissions with Diagnosis Related Group codes for coronary procedures without myocardial infarction, 106, 107, 112, 124) were classified as “acute” and all others were classified as “non-acute.”

b

Patients who received both tests are also included in preceding individual test groups.